THC · Company research
Tenet Healthcare Corporation New (THC): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
31records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Is Tenet Healthcare (THC) Worth More After Raising Its Outlook? - Yahoo Finance | Is Tenet Healthcare (THC) Worth More After Raising Its Outlook? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 18, 2026 | neutral | 0 | 0.6 |
| Tenet Healthcare (THC) Lifts 2026 Outlook, Is The Upside Already Priced In? - Yahoo Finance | Tenet Healthcare (THC) Lifts 2026 Outlook, Is The Upside Already Priced In? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 17, 2026 | neutral | 0 | 0.6 |
| Learn Why The Bull Case For Tenet Healthcare Stock Could Change Following Guidance Raise - Yahoo Finance | Learn Why The Bull Case For Tenet Healthcare Stock Could Change Following Guidance Raise Yahoo Finance | View source ↗ | Yahoo Finance | Oct 17, 2026 | neutral | 0 | 0.6 |
| Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term | Tenet Healthcare (THC) is featured as a stock to watch with a #3 (Hold) Zacks Rank and an A-rated VGM Score. The company demonstrates strong growth potential with a Growth Style Score of B and forecasted year-over-year earnings growth of 25.4% for the current fiscal year. One analyst revised earnings estimates upward in the last 60 days, with the Zacks Consensus Estimate increasing to $21.04 per share. | View source ↗ | Zacks Investment Research | Oct 16, 2026 | bullish | 1 | 1 |
| Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term | Tenet Healthcare (THC) is featured as a stock to watch with a #3 (Hold) Zacks Rank and an A-rated VGM Score. The company demonstrates strong growth potential with a Growth Style Score of B and forecasted year-over-year earnings growth of 25.4% for the current fiscal year. One analyst revised earnings estimates upward in the last 60 days, with the Zacks Consensus Estimate increasing to $21.04 per share. | View source ↗ | Zacks Investment Research | Oct 16, 2026 | bullish | 1 | 1 |
| Why Tenet Healthcare (THC) Outpaced the Stock Market Today | Tenet Healthcare (THC) closed at $275.13, up 1.3%, outperforming the S&P 500's 0.33% gain. The hospital operator is expected to report Q3 2026 earnings of $4.59 per share (up 24.05% YoY) with revenue of $5.47 billion (up 3.4% YoY). Full-year estimates project $21.04 EPS and $22.2 billion revenue. THC holds a Zacks Rank #3 (Hold) with a Forward P/E of 12.91, trading in line with its industry average. The Medical-Hospital industry ranks 195th out of 250+ industries. | View source ↗ | Zacks Investment Research | Oct 15, 2026 | neutral | 0 | 1 |
| Why Tenet Healthcare (THC) Outpaced the Stock Market Today | Tenet Healthcare (THC) closed at $275.13, up 1.3%, outperforming the S&P 500's 0.33% gain. The hospital operator is expected to report Q3 2026 earnings of $4.59 per share (up 24.05% YoY) with revenue of $5.47 billion (up 3.4% YoY). Full-year estimates project $21.04 EPS and $22.2 billion revenue. THC holds a Zacks Rank #3 (Hold) with a Forward P/E of 12.91, trading in line with its industry average. The Medical-Hospital industry ranks 195th out of 250+ industries. | View source ↗ | Zacks Investment Research | Oct 15, 2026 | neutral | 0 | 1 |
| Why Tenet Healthcare (THC) Outpaced the Stock Market Today - Yahoo Finance | Why Tenet Healthcare (THC) Outpaced the Stock Market Today Yahoo Finance | View source ↗ | Yahoo Finance | Oct 15, 2026 | neutral | 0 | 0.6 |
| TCBI,AMTB,CAG,JEF,UFPI,THC,DHR,NUE | Stock Prices | Quote Comparison - Yahoo! Finance Canada | TCBI,AMTB,CAG,JEF,UFPI,THC,DHR,NUE | Stock Prices | Quote Comparison Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| Tenet Healthcare Corporation (THC) Stock Forecasts - Yahoo Finance | Tenet Healthcare Corporation (THC) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| THC Oct 2026 310.000 put (THC261016P00310000) Stock Price, News, Quote & History - Yahoo! Finance Canada | THC Oct 2026 310.000 put (THC261016P00310000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 12, 2026 | neutral | 0 | 0.6 |
| Tenet Healthcare Corporation (THC) Stock forecasts - Yahoo Finance UK | Tenet Healthcare Corporation (THC) Stock forecasts Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 10, 2026 | neutral | 0 | 0.6 |
| RBC Capital Reaffirms Their Buy Rating on Tenet Healthcare (THC) - The Globe and Mail | RBC Capital Reaffirms Their Buy Rating on Tenet Healthcare (THC) The Globe and Mail | View source ↗ | The Globe and Mail | Oct 10, 2026 | neutral | 0 | 0.6 |
| Tenet Healthcare (THC) Beats Stock Market Upswing: What Investors Need to Know | Tenet Healthcare closed at $263.78, up 1.23% and outpacing the S&P 500's 0.6% gain. The hospital operator is expected to report Q3 EPS of $4.59 (up 24.05% YoY) and revenue of $5.47 billion (up 3.4% YoY) on October 29, 2026. With a Zacks Rank of #3 (Hold) and Forward P/E of 12.39, THC trades in line with its industry average valuation. | View source ↗ | Zacks Investment Research | Oct 9, 2026 | neutral | 0 | 1 |
| Insider Sale: Director at $THC Sells 1,969 Shares - Quiver Quantitative | Insider Sale: Director at $THC Sells 1,969 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 9, 2026 | neutral | 0 | 0.6 |
| Tenet Healthcare Corporation (THC) Stock Forecasts - Yahoo Finance | Tenet Healthcare Corporation (THC) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term | Tenet Healthcare (THC) receives a #3 (Hold) rating on the Zacks Rank with a VGM Score of B. The company benefits from attractive valuation metrics including a forward P/E ratio of 12.35 and a Value Style Score of A. Two analysts revised earnings estimates upward in the last 60 days, with the Zacks Consensus Estimate increasing $0.75 to $21.04 per share, and the company maintains an average earnings surprise of +22.7%. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term | Tenet Healthcare (THC) receives a #3 (Hold) rating on the Zacks Rank with a VGM Score of B. The company benefits from attractive valuation metrics including a forward P/E ratio of 12.35 and a Value Style Score of A. Two analysts revised earnings estimates upward in the last 60 days, with the Zacks Consensus Estimate increasing $0.75 to $21.04 per share, and the company maintains an average earnings surprise of +22.7%. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term | Tenet Healthcare (THC) receives a #3 (Hold) rating on the Zacks Rank with a VGM Score of B. The company benefits from attractive valuation metrics including a forward P/E ratio of 12.35 and a Value Style Score of A. Two analysts revised earnings estimates upward in the last 60 days, with the Zacks Consensus Estimate increasing $0.75 to $21.04 per share, and the company maintains an average earnings surprise of +22.7%. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | bullish | 1 | 1 |
| Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know | Tenet Healthcare (THC) is receiving increased investor attention. The stock has underperformed the S&P 500 over the past month (-3.4% vs +1.4%). While the company beat earnings and revenue estimates in recent quarters with strong EPS growth of +25.4% expected for the current fiscal year, the Zacks Rank #3 (Hold) rating suggests the stock may perform in line with the broader market in the near term. The company trades at a valuation discount to peers. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | neutral | 0 | 1 |
| Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know | Tenet Healthcare (THC) is receiving increased investor attention. The stock has underperformed the S&P 500 over the past month (-3.4% vs +1.4%). While the company beat earnings and revenue estimates in recent quarters with strong EPS growth of +25.4% expected for the current fiscal year, the Zacks Rank #3 (Hold) rating suggests the stock may perform in line with the broader market in the near term. The company trades at a valuation discount to peers. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | neutral | 0 | 1 |
| Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know | Tenet Healthcare (THC) is receiving increased investor attention. The stock has underperformed the S&P 500 over the past month (-3.4% vs +1.4%). While the company beat earnings and revenue estimates in recent quarters with strong EPS growth of +25.4% expected for the current fiscal year, the Zacks Rank #3 (Hold) rating suggests the stock may perform in line with the broader market in the near term. The company trades at a valuation discount to peers. | View source ↗ | Zacks Investment Research | Oct 8, 2026 | neutral | 0 | 1 |
| Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance | Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance | View source ↗ | Yahoo Finance | Oct 8, 2026 | neutral | 0 | 0.6 |
| How the federal hemp ban treats delta-8 THC differently – and what operators are doing - MJBizDaily | How the federal hemp ban treats delta-8 THC differently – and what operators are doing MJBizDaily | View source ↗ | MJBizDaily | Oct 5, 2026 | neutral | 0 | 0.6 |
| Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know | Tenet Healthcare stock rose 1.83% to $258.62, outperforming the S&P 500's 0.73% gain. The hospital operator is projected to report Q3 EPS of $4.59 (up 24.05% YoY) and revenue of $5.47 billion (up 3.4% YoY). For the full year, earnings are forecast at $21.04 per share and revenue at $22.2 billion. THC holds a Zacks Rank #3 (Hold) with a Forward P/E of 12.07 and PEG ratio of 0.97. | View source ↗ | Zacks Investment Research | Oct 2, 2026 | neutral | 0 | 1 |
| Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know - Yahoo! Finance Canada | Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 2, 2026 | neutral | 0 | 0.6 |
| Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance | Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know Yahoo Finance | View source ↗ | Yahoo Finance | Oct 2, 2026 | neutral | 0 | 0.6 |
| Can THC's Cash Flow Support Its Expanding Capital-Return Strategy? - TradingView | Can THC's Cash Flow Support Its Expanding Capital-Return Strategy? TradingView | View source ↗ | TradingView | Sep 30, 2026 | neutral | 0 | 0.6 |
| Tenet Healthcare (THC): Buy, Sell, or Hold Post Q2 Earnings? - StockStory | Tenet Healthcare (THC): Buy, Sell, or Hold Post Q2 Earnings? StockStory | View source ↗ | StockStory | Sep 30, 2026 | neutral | 0 | 0.6 |
| Here’s How Much You Would Have Made Owning Tenet Healthcare Stock In The Last 10 Years - Benzinga | Here’s How Much You Would Have Made Owning Tenet Healthcare Stock In The Last 10 Years Benzinga | View source ↗ | Benzinga | Sep 29, 2026 | neutral | 0 | 0.6 |
| Is Tenet Healthcare (THC) Outperforming Other Medical Stocks This Year? - Yahoo Finance | Is Tenet Healthcare (THC) Outperforming Other Medical Stocks This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 28, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.